Pathogenesis and management of iron overload in thalassemia.
D003676:Deferoxamine / Q000627:therapeutic use*; D006432:Hemochromatosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007501:Iron / Q000378:metabolism*; D004369:Pentetic Acid / Q000627:therapeutic use*; D013789:Thalassemia / Q000150:complications* / Q000378:metabolism / Q000628:therapy
D004369:Pentetic Acid; D007501:Iron; D003676:Deferoxamine